Extrapolating Prognostic Factors of Primary Curative Resection to Postresection Recurrences Hepatocellular Carcinoma Treatable by Radiofrequency Ablation

Figure 1

Worse primary tumor differentiation and short time to recurrence after curative resection bode poorly for clinical outcomes of recurrent hepatocellular carcinoma undergoing radiofrequency ablation. Univariate analyses of primary tumor differentiation demonstrated that worse tumor differentiation was associated with poorer overall survival (OS) rates (a) and poorer recurrence-free survival (RFS) rates (b) (Kaplan-Meier and log-rank tests). Prognostic performance of primary tumor differentiation was significant for both OS and RFS ( and , respectively). Univariate analyses of time to recurrence after curative resection demonstrated that short time to recurrence was associated with poorer OS rates (c) and poorer RFS rates (d) (Kaplan-Meier and log-rank tests). Prognostic performance of time to recurrence after curative resection was significant for both OS and RFS ( and , respectively).

(a)

(b)

(c)

(d)